Bimatoprost ophthalmic Pregnancy and Breastfeeding Warnings
Bimatoprost ophthalmic is also known as: Lumigan
Bimatoprost ophthalmic Pregnancy Warnings
Bimatoprost ophthalmic solution has been assigned to pregnancy category C by the FDA. Animal data have revealed evidence of embryolethality, fetotoxicity, teratogenicity, and decreased neonatal viability with high oral doses (33 to 97 times the human AUC). Bimatoprost undergoes minimal systemic absorption after ocular administration. There are no controlled data in human pregnancy. Bimatoprost is only recommended for use during pregnancy when benefit outweighs risk.
Bimatoprost ophthalmic Breastfeeding Warnings
There are no data on the excretion of topically administered bimatoprost or its metabolites into human milk. It is excreted into breast milk in animals. It undergoes minimal systemic absorption after ocular administration. The manufacturer recommends that caution be used when administering bimatoprost ophthalmic to nursing women.
In animal studies, bimatoprost was excreted in breast milk.
- Bimatoprost use while Breastfeeding (in more detail)
- bimatoprost drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.